These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 31201557)

  • 1. Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology.
    Taylor DL; Gough A; Schurdak ME; Vernetti L; Chennubhotla CS; Lefever D; Pei F; Faeder JR; Lezon TR; Stern AM; Bahar I
    Handb Exp Pharmacol; 2019; 260():327-367. PubMed ID: 31201557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADME-Tox in drug discovery: integration of experimental and computational technologies.
    Yu H; Adedoyin A
    Drug Discov Today; 2003 Sep; 8(18):852-61. PubMed ID: 12963322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.
    Agoram BM; Demin O
    Drug Discov Today; 2011 Dec; 16(23-24):1031-6. PubMed ID: 22020181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine.
    Stern AM; Schurdak ME; Bahar I; Berg JM; Taylor DL
    J Biomol Screen; 2016 Jul; 21(6):521-34. PubMed ID: 26962875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Experimental Models of the Liver to Predict Human Drug Hepatotoxicity and Efficacy.
    Vernetti LA; Vogt A; Gough A; Taylor DL
    Clin Liver Dis; 2017 Feb; 21(1):197-214. PubMed ID: 27842772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of the microphysiology systems database for experimental ADME-Tox and disease models.
    Schurdak M; Vernetti L; Bergenthal L; Wolter QK; Shun TY; Karcher S; Taylor DL; Gough A
    Lab Chip; 2020 Apr; 20(8):1472-1492. PubMed ID: 32211684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
    Fleisher B; Brown AN; Ait-Oudhia S
    Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.
    Geerts H; Wikswo J; van der Graaf PH; Bai JPF; Gaiteri C; Bennett D; Swalley SE; Schuck E; Kaddurah-Daouk R; Tsaioun K; Pelleymounter M
    CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):5-20. PubMed ID: 31674729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases.
    Li P; Chen J; Wang J; Zhou W; Wang X; Li B; Tao W; Wang W; Wang Y; Yang L
    J Ethnopharmacol; 2014; 151(1):93-107. PubMed ID: 23850710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors.
    Saydmohammed M; Jha A; Mahajan V; Gavlock D; Shun TY; DeBiasio R; Lefever D; Li X; Reese C; Kershaw EE; Yechoor V; Behari J; Soto-Gutierrez A; Vernetti L; Stern A; Gough A; Miedel MT; Lansing Taylor D
    Exp Biol Med (Maywood); 2021 Nov; 246(22):2420-2441. PubMed ID: 33957803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Systems Pharmacology: A Case for Disease Models.
    Musante CJ; Ramanujan S; Schmidt BJ; Ghobrial OG; Lu J; Heatherington AC
    Clin Pharmacol Ther; 2017 Jan; 101(1):24-27. PubMed ID: 27709613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.
    Ayyar VS; Jusko WJ
    Pharmacol Rev; 2020 Apr; 72(2):414-438. PubMed ID: 32123034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent applications of quantitative systems pharmacology and machine learning models across diseases.
    Aghamiri SS; Amin R; Helikar T
    J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):19-37. PubMed ID: 34671863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems Pharmacology in Small Molecular Drug Discovery.
    Zhou W; Wang Y; Lu A; Zhang G
    Int J Mol Sci; 2016 Feb; 17(2):246. PubMed ID: 26901192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Systems Pharmacology for Rare Disease Drug Development.
    Bai JP; Wang J; Zhang Y; Wang L; Jiang X
    J Pharm Sci; 2023 Sep; 112(9):2313-2320. PubMed ID: 37422281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.
    Nigam SK; Bush KT; Bhatnagar V; Poloyac SM; Momper JD
    Clin Pharmacol Ther; 2020 Jul; 108(1):40-53. PubMed ID: 32119114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An introduction to QSP modeling for pharmacologists].
    Sayama H; Nagasaka Y; Tabata K
    Nihon Yakurigaku Zasshi; 2019; 154(3):143-150. PubMed ID: 31527365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal Circuit-Based Computer Modeling as a Phenotypic Strategy for CNS R&D.
    Geerts H; Barrett JE
    Front Neurosci; 2019; 13():723. PubMed ID: 31379482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance and potential roles of microphysiological systems in biology and medicine.
    Wikswo JP
    Exp Biol Med (Maywood); 2014 Sep; 239(9):1061-72. PubMed ID: 25187571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.